Biotechgate Global Database ›
News in the Life Sciences Industry | |
| Results 421 - 440 out of 500 displayed. | |
| « 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » | |
Caladrius Biosciences to Participate at Upcoming December Conferences |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: Caladrius Biosciences, Inc |
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: Paratek Pharmaceuticals, Inc. |
Cerner Achieves 500th Patent With Voice-Assisted Technology |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: Cerner Corporation |
XOMA Announces Commencement of Rights Offering |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: XOMA Corporation |
AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: AllianceBernstein L.P. |
AGTC Announces Departure of Chief Medical Officer, Company on Track to Announce XLRP and ACHM Data in January 2020 |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: Applied Genetic Technologies Corp. (AGTC) |
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| Read more ›› |
| By: GlobenewsWire - 02 Dec 2019 |
| Related companies: Radius Health, Inc. |
New clues link genomic origins of memory impairment |
MANHASSET, N.Y., Dec. 2, 2019 /PRNewswire/ -- For the first time, scientists have linked memory impairment in mammals with the expression of endogenous retroviruses (ERVs) within an organism's genome. The research, conducted at The Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
The global medical device security solutions market at a CAGR of over 8% during the forecast period |
NEW YORK, Dec. 2, 2019 /PRNewswire/ -- Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
NOUS Imaging Announces $6.6 Million in Funding for Brain MRI Software Solution |
ST. LOUIS, Dec. 2, 2019 /PRNewswire/ -- Nearly 8 million patients in the U.S. underwent brain MR scans last year. However, patient movement during the procedure has invalidated just under 20% of those scans, costing up to $4 billion in unnecessary costs while also posing potential safety risks. |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
Global Neonatal Infant Care Device Market Study 2019-2023: Market Opportunities, in Terms of Hard Numbers, Unmet Needs, and Game Changing Strategies |
DUBLIN, Dec. 2, 2019 /PRNewswire/ -- The Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
Amgen Announces Data Being Presented At ASH 2019 |
THOUSAND OAKS, Calif., Dec. 2, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new clinical data from its oncology in-line products and pipeline that will be presented at the 61(st) American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Dec. 7-10, 2019. Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
| Related companies: Amgen, Inc. |
ViewRay Announces Collaborations with Elekta and Medtronic |
CLEVELAND, Dec. 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB (Nasdaq: EKTA-B.ST) ("Elekta") to advance the knowledge and use of MR-guided radiation therapy. In connection with... Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
| Related companies: ViewRay, Inc. |
Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study |
FREMONT, Calif., Dec. 2, 2019 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases, announced that it will hold a conference call tomorrow, December 3, at... Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
| Related companies: Ardelyx, Inc. |
ViewRay Announces Proposed Public Offering of Common Stock |
CLEVELAND, Dec. 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of $75.0 million of shares... Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
| Related companies: ViewRay, Inc. |
NanoVibronix to Present at Two Investor Conferences in December |
ELMSFORD, N.Y., Dec. 2, 2019 /PRNewswire/ -- Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
The point-of-care diagnostics market is projected to grow at a CAGR of 10.4% from 2019 to 2024 |
The point-of-care diagnostics market is projected to grow at a CAGR of 10.4% from 2019 to 2024. |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
Seasonal Influenza Vaccines: Global Drug Forecast and Market Analysis to 2028 |
Seasonal Influenza Vaccines: Global Drug Forecast and Market Analysis to 2028 Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
Three Day Introduction to the European Medical Device Regulation Seminar - London, United Kingdom - May 13-15, 2020 |
DUBLIN, Dec. 2, 2019 /PRNewswire/ -- The Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
Lilly to Participate in Evercore ISI 2nd Annual HealthCONx Conference |
INDIANAPOLIS, Dec. 2, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 2(nd) Annual HealthCONx Conference on Wednesday, December 4, 2019. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific Officer and President of Lilly Research Laboratories, will... Read more ›› |
| By: PR Newswire Association LLC. - 02 Dec 2019 |
| Related companies: Eli Lilly and Company |
| « 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Partners
Upcoming Life Sciences Events
- December 2019
- Marseille: BioFIT
- London: Genesis 2019
- London: The Pharma Business Development Course
